Rheumatology - European Medical Journal

Aims and Scope

EMJ Rheumatology is an open access, peer-reviewed eJournal committed to publishing the highest quality medical research concerning all aspects rheumatic function and disease to help advance the development of this field.

The journal is published annually, six weeks after the European Alliance of Associations for Rheumatology (EULAR) Congress, and features highlights from this congress, alongside interviews with experts in the field, reviews of abstracts presented at the congress, as well as in-depth features on congress sessions. Additionally, this journal covers advances within the clinical and pharmaceutical arenas by publishing sponsored content from congress symposia, which is of high educational value for healthcare professionals. This undergoes rigorous quality control checks by independent experts and the in-house editorial team.

EMJ Rheumatology also publishes peer-reviewed research papers, review articles, and case reports in the field. In addition, the journal welcomes the submission of features and opinion pieces intended to create a discussion around key topics in the field and broaden readers’ professional interests. EMJ Rheumatology is managed by a dedicated editorial team that adheres to a rigorous double-blind peer-review process, maintains high standards of copy editing, and ensures timely publication.

EMJ Rheumatology endeavours to increase knowledge, stimulate discussion, and contribute to a better understanding of rheumatic diseases. Our focus is on research that is relevant to all healthcare professionals in the field. We do not publish veterinary science papers or laboratory studies not linked to patient outcomes. We have a particular interest in topical studies that advance research and inform of coming trends affecting clinical practice in rheumatology.

Topics include (but are not limited to):

  • Inflammatory arthritis
  • Osteoarthritis
  • Paediatric and adolescent rheumatological disease
  • Vasculitis
  • Connective tissue diseases
  • Auto-inflammatory disorders
  • Guidelines in rheumatology practice
  • Spondyloarthropathies
  • Immunodeficiency states (primary and secondary)
  • Sjögren’s syndrome
  • Treatment issues of rheumatic disease
  • Rheumatic musculoskeletal disease
  • Immunity in rheumatic diseases
  • Rheumatic arthritis
  • Epidemiology
  • Bone diseases
  • Systemic sclerosis
  • Myositis
  • Orphan/rare diseases
  • Biosimilars